The North America synthetic biology market is expected to grow from US$ 4,313.62 million in 2021 to US$ 15,223.61 million by 2028; it is estimated to grow at a CAGR of 19.7% from 2021 to 2028.

Synthetic biology is an emerging concept that has numerous applications in the chemicals, agriculture, pharmaceuticals, and energy industries. Various start-ups offer gene synthesis products/services for biological processes. For example, Benchling provides CAD tools, GenScript offers gene synthesis, Ginkgo Bioworks assists in organism engineering, Transcriptis (a bioinformatics company) offers solutions facilitating cloud labs/automation, and Glowee offers consumer products. Amid the adverse effects of the COVID-19 pandemic on start-up performance, the bioeconomy accelerated in the first half of 2020. 56 synthetic biology businesses raised more than US$ 3 billion in equity financing in the first half of 2020, compared to 65 companies raising US$ 1.9 billion during the same period in 2020. The new generation of biopharma businesses uses synthetic biology to improve cell treatment and gene therapy and support early cancer detection. With such rising investments by companies, the demand for synthetic biology-based new techniques is increasing, thereby driving the synthetic biology market growth across the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America synthetic biology market . The North America synthetic biology market is expected to grow at a notable CAGR during the forecast period.

North America Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

North America Synthetic Biology Market Segmentation

The North America synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to be fastest growing during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to be fastest growing during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to grow at the fastest rate during the forecast period. The North America synthetic biology market is segmented into the US, Canada, and Mexico.

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the North America synthetic biology market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Synthetic Biology Market – By Product
1.3.2 North America Synthetic Biology Market – By Technology
1.3.3 North America Synthetic Biology Market – By Application
1.3.4 North America Synthetic Biology Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Synthetic Biology Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Synthetic Biology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Investments in Synthetic Biology
5.1.2 Accentuating Number of Start-Ups
5.2 Key Market Restraints
5.2.1 Renewed Regulations for Biotechnology
5.3 Key Market Opportunities
5.3.1 Collaboration Between Companies
5.4 Future Trends
5.4.1 Advanced Synthetic Biology
5.5 Impact Analysis
6. Synthetic Biology Market– North America Analysis
6.1 North America Synthetic Biology Market Revenue Forecast and Analysis
7. North America Synthetic Biology Market Analysis – By Product
7.1 Overview
7.2 North America Synthetic Biology Market, By Product, 2021 & 2028 (%)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzyme: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Oligonucleotides
7.4.1 Overview
7.4.2 Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Chassis Organisms
7.5.1 Overview
7.5.2 Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Xeno-Nucleic Acids
7.6.1 Overview
7.6.2 Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
8. North America Synthetic Biology Market Analysis – By Technology
8.1 Overview
8.2 North America Synthetic Biology Market Share by Technology – 2021 & 2028 (%)
8.3 Gene Synthesis
8.3.1 Overview
8.3.2 Gene Synthesis: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genome Engineering
8.4.1 Overview
8.4.2 Genome Engineering: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.5 Measurement and Modeling
8.5.1 Overview
8.5.2 Measurement and Modeling: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.6 Cloning and Sequencing
8.6.1 Overview
8.6.2 Cloning and Sequencing: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.7 Nanotechnology
8.7.1 Overview
8.7.2 Nanotechnology: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9. North America Synthetic Biology Market Analysis – By Application
9.1 Overview
9.2 North America Synthetic Biology Market Share by Application – 2021 & 2028 (%)
9.3 Medical Applications
9.3.1 Overview
9.3.2 Medical Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.3.2.1 Drug Discovery and Therapeutics
9.3.2.1.1 Overview
9.3.2.1.2 Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.3.2.2 Pharmaceuticals
9.3.2.2.1 Overview
9.3.2.2.2 Pharmaceuticals: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.4 Industrial Applications
9.4.1 Overview
9.4.2 Industrial Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.5 Food & Agriculture
9.5.1 Overview
9.5.2 Food & Agriculture: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.6 Environmental Applications
9.6.1 Overview
9.6.2 Environmental Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
10. North America Synthetic Biology Market – Country Analysis
10.1 North America: Synthetic Biology Market
10.1.1 Overview
10.1.2 North America Synthetic Biology Market Revenue and Forecasts to 2028, By Country (%)
10.1.2.1 US: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.3 US: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.2.1.4 US: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.2.1.5 US: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.2.1.6 US: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.2.2 Canada: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.3 Canada: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.2.2.5 Canada: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.2.2.6 Canada: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.2.3 Mexico: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.3 Mexico: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.2.3.5 Mexico: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.2.3.6 Mexico: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Agilent Technologies, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MERCK KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 New England Biolabs
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Integrated DNA Technologies
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Twist Bioscience
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GenScript Biotech Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novozymes A/S
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Codexis
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amyris Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Synthetic Biology Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. US: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 3. US: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 4. US: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 5. US: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 6. Canada: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 7. Canada: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 8. Canada: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 9. Canada: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 10.   Mexico: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 11.   Mexico: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 12.   Mexico: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 13.   Mexico: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 14.   Organic Developments
Table 15.   Inorganic Developments
Table 16.   Glossary of Terms
 
 

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America synthetic biology market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the North America synthetic biology market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the synthetic biology market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – North America Synthetic Biology Market

● Agilent Technologies, Inc.
● Amyris
● Codexis
● Genscript Biotech corporation
● Integrated DNA Technologies
● Merck KGaA
● New England Biolabs
● Novozymes A/S
● Thermo Fisher Scientific
● Twist Bioscience